北京大学学报(医学版) ›› 2017, Vol. 49 ›› Issue (4): 632-637. doi: 10.3969/j.issn.1671-167X.2017.04.015

• 论著 • 上一篇    下一篇

输尿管镜活检可协助上尿路尿路上皮癌危险分层

马闰卓1*,邱敏1*,何为1,杨斌1,夏海缀1,邹达1,陆敏2,马潞林1,卢剑1△   

  1. (北京大学第三医院1. 泌尿外科, 2. 病理科, 北京100191)
  • 出版日期:2017-08-18 发布日期:2017-08-18
  • 通讯作者: 卢剑 E-mail: lujian@bjmu.edu.cn

Ureteroscope can assist risk stratification in upper tract urothelial carcinoma

MA Runzhuo1*, QIU Min1*, HE Wei1, YANG Bin1, XIA Haizhui1, ZOU Da1, LU Min2, MA Lulin1, LU Jian1△   

  1. (1.Department of Urology, 2. Department of Pathology, Peking University Third Hospital, Beijing 100191, China)
  • Online:2017-08-18 Published:2017-08-18
  • Contact: LU Jian E-mail: lujian@bjmu.edu.cn

摘要: 目的:分析输尿管镜活检对上尿路尿路上皮癌(upper tract urothelial carcinoma,UTUC)患者肿瘤级别、肌层浸润以及多灶性诊断的准确性,分析术后肿瘤级别及肌层浸润的相关因素,探讨输尿管镜活检对UTUC患者术前危险分层的可行性与必要性。方法:回顾性分析北京大学第三医院泌尿外科2014年1月至2016年12月间输尿管镜活检后行肾、输尿管全长及膀胱输尿管口袖状切除术患者的临床资料。结果:患者76例,男性31例(40.8%)、女性45例(59.2%),平均年龄64.5岁(31~88岁)。肿瘤位于左侧35例、右侧41例,肾盂39例、输尿管37例,症状为肉眼血尿者51例。术后病理提示低级别21例(27.6%)、高级别51例(67.1%),未确定级别4例(5.3%);非肌层浸润27例(35.5%)、肌层浸润47例(61.9%),无法确认是否浸润2例(2.6%);术后病理均为UTUC。在50名输尿管镜活检可判断肿瘤级别的患者中,活检病理对低级别尿路上皮癌诊断的敏感性、特异性和准确性分别为88.2%、69.7%和76.0%,阳性和阴性预测值分别为60.0%和92.0%。在27例活检病理可以判断是否有肌层浸润的患者中,5例活检报告为肌层浸润的UTUC患者术后病理结果均有肌层浸润,22例报告为非肌层浸润的患者术后肌层浸润和非肌层浸润各占50%,总准确性为59.3%。输尿管镜活检对于肿物多灶性诊断的准确性为61.0%。单因素分析显示,输尿管镜活检级别与术后UTUC级别相关(P=0.001),而性别、年龄、边侧、体重指数(body mass index,BMI)、血尿、术前肾小球滤过率估计值(estimated glomerular filtration rate,eGFR)、泌尿系积水、肿瘤大小、位置、多灶性及是否有蒂均与术后UTUC级别无显著相关性。输尿管镜活检病理高级别(P=0.02)、术前eGFR<90 mL/(min·1.73 m2)(P=0.025)以及病变位于肾盂(P=0.049)与肌层浸润显著相关,性别、年龄、边侧、BMI、血尿、泌尿系积水、肿瘤大小、多灶性及是否有蒂与其无显著相关性。结论:输尿管镜活检可协助对UTUC患者进行危险分层。

关键词: 尿路上皮癌, 输尿管镜检查, 活组织检查, 肺癌分级

Abstract: Objective: To analyze the efficiency of ureteroscope and biopsy in the diagnosis of tumor grade, muscle-invasiveness and multifocality in suspected upper tract urinary carcinoma (UTUC) patients in order to find out whether it can be used in the risk stratification of UTUC patients. Methods: A retrospective study of 76 UTUC patients who underwent preoperative ureteroscope and/or biopsy and received radical nephroureterectomy in Peking University Third Hospital during January 2014 to December 2016 was undertaken. Results: In this study, 76 patients were included. There were 31 males (40.8%), and 45 females (59.2%). The median age was 64.5 years (31-88), and 51 patients had the symptom of hematuresis. The tumor was located in renal pelvis in 39 patients, and in ureter in 37 patients. Post-operative pathology confirmed that all the 76 patients included in this study suffered from UTUC, of whom 21 (21.6%) were of low-grade, 51 (67.1%) were of high-grade, 4 (5.3%) were undetermined, and 47 (61.9%) patients were muscle-invasive, and 27 (35.5%) were not, and 2 (2.6%) were undetermined. Among the 50 patients, in whom the grade of the tumor could be diagnosed by biopsy, the sensitivity, specificity, accuracy, positive predictive value and negative predictive value for low-grade tumor was 88.2%, 69.7%, 76.0%, 60.0% and 92.0%, respectively. Among the 27 patients, in whom the muscle-invasiveness could be diagnosed by biopsy, 5 patients were diagnosed with muscle-invasiveness, all confirmed by pathology after surgery and 22 patients were diagnosed with none muscle-invasiveness, turned out to be 50% muscle-invasive and 50% none-muscle invasive after surgery. The accuracy was 59.3%. The accuracy of ureteroscopic biopsy to diagnosis multifocality was 61.0%. On univariate ana-lysis, biopsy grade was associated with postoperative pathology (P=0.001), while gender, age, side, body mass index (BMI), hematuresis, preoperative estimated glomerular filtration rate (eGFR), hydronephrosis, tumor size, location, multifocality and sessile were not associated with postoperative pathology grade. Biopsy grade (P=0.02), preoperative eGFR<90 mL/(min·1.73 m2)(P=0.025) and tumor located in pelvis (P=0.049) were associated with muscle invasiveness. Gender, age, side, BMI, hematuresis, hydronephrosis, tumor size, multifocality and sessile were not significantly associated with muscle invasiveness. Conclusion: Ureteroscope and biopsy can assist risk stratification in upper tract urothelial carcinoma patients.

Key words: Urothelial carcinoma, Ureteroscopy, Biopsy, Neoplasm grading

中图分类号: 

  •  
[1] 李志存, 吴天俣, 梁磊, 范宇, 孟一森, 张骞. 穿刺活检单针阳性前列腺癌术后病理升级的危险因素分析及列线图模型构建[J]. 北京大学学报(医学版), 2024, 56(5): 896-901.
[2] 田宇轩,阮明健,刘毅,李德润,吴静云,沈棋,范宇,金杰. 双参数MRI改良PI-RADS评分4分和5分病灶的最大径对临床有意义前列腺癌的预测效果[J]. 北京大学学报(医学版), 2024, 56(4): 567-574.
[3] 姚凯烽,阮明健,李德润,田宇轩,陈宇珂,范宇,刘毅. 靶向穿刺联合区域系统穿刺对PI-RADS 4~5分患者的前列腺癌诊断效能[J]. 北京大学学报(医学版), 2024, 56(4): 575-581.
[4] 刘毅,袁昌巍,吴静云,沈棋,肖江喜,赵峥,王霄英,李学松,何志嵩,周利群. 靶向穿刺+6针系统穿刺对PI-RADS 5分患者的前列腺癌诊断效能[J]. 北京大学学报(医学版), 2023, 55(5): 812-817.
[5] 袁昌巍,李德润,李志华,刘毅,山刚志,李学松,周利群. 多参数磁共振成像中动态对比增强状态在诊断PI-RADS 4分前列腺癌中的应用[J]. 北京大学学报(医学版), 2023, 55(5): 838-842.
[6] 田聪,刘军,杨波,乔佳佳,黄晓波,许清泉. 经皮肾镜取石术中异常肾盂黏膜活检结果分析[J]. 北京大学学报(医学版), 2023, 55(5): 948-952.
[7] 郑丹枫,李君禹,李佳曦,张英爽,钟延丰,于淼. 青少年特发性脊柱侧凸椎旁肌的病理特征[J]. 北京大学学报(医学版), 2023, 55(2): 283-291.
[8] 张崔建,何志嵩,周利群. 上尿路尿路上皮癌的淋巴清扫[J]. 北京大学学报(医学版), 2022, 54(4): 592-594.
[9] 戴翔,王飞,杜依青,宋宇轩,徐涛. 上尿路尿路上皮癌组织中脂肪因子表达与临床病理特征及预后的相关性[J]. 北京大学学报(医学版), 2022, 54(4): 605-614.
[10] 李志华,徐纯如,刘颖,贯华,张萌,车新艳,唐琦,黄燕波,李学松,周利群. 饮水习惯与上尿路尿路上皮癌病理特征的相关性分析[J]. 北京大学学报(医学版), 2022, 54(4): 621-627.
[11] 郝一昌,颜野,张帆,邱敏,周朗,刘可,卢剑,肖春雷,黄毅,刘承,马潞林. 穿刺活检单针阳性的前列腺癌手术策略选择及经验总结[J]. 北京大学学报(医学版), 2020, 52(4): 625-631.
[12] 关豹,翁迈,凡航,彭鼎,方冬,熊耕砚,李学松,周利群. 术前贫血对上尿路尿路上皮癌预后的影响: 单中心686例患者回顾性研究[J]. 北京大学学报(医学版), 2019, 51(6): 1056-1061.
[13] 吴进锋,林榕城,林友成,蔡旺海,朱庆国,方冬,熊耕砚,张雷,周利群,叶烈夫,李学松. 肾输尿管全长切除术两种不同术式的双中心疗效对比[J]. 北京大学学报(医学版), 2019, 51(4): 646-652.
[14] 马闰卓,夏海缀,陆敏,张智荧,张启鸣,卢剑,王国良,马潞林. 输尿管镜活体组织检查对上尿路尿路上皮癌根治性手术的影响[J]. 北京大学学报(医学版), 2019, 51(4): 665-672.
[15] 程嗣达,李万强,穆莉,丁光璞,张博,谌诚,应泽伟,杨昆霖,郝瀚,李学松,周利群. 全腹膜外途径膀胱瓣肾盂吻合自体肾移植术在上尿路尿路上皮癌治疗中的应用[J]. 北京大学学报(医学版), 2019, 51(4): 758-763.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!